BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8687139)

  • 1. Mechanisms of resistance to 6-aminonicotinamide.
    Saunders PP; Muhs MA; Arimilli S
    Anticancer Res; 1996; 16(2):843-8. PubMed ID: 8687139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique bioactivation of tiazofurin--studies with resistant cells.
    Kuttan R
    Indian J Biochem Biophys; 1989 Jun; 26(3):160-5. PubMed ID: 2620910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical mechanisms of resistance to tiazofurin.
    Jayaram HN
    Adv Enzyme Regul; 1985; 24():67-89. PubMed ID: 3835825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase.
    Fridland A; Connelly MC; Robbins TJ
    Cancer Res; 1986 Feb; 46(2):532-7. PubMed ID: 3000575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and action of benzamide riboside in Chinese hamster ovary cells.
    Saunders PP; Arimilli S; Krohn K; Muhs MA; Alvarez E; Surve-lyer R
    Anticancer Drugs; 1996 Jan; 7(1):93-9. PubMed ID: 8742104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin.
    Ahluwalia GS; Jayaram HN; Plowman JP; Cooney DA; Johns DG
    Biochem Pharmacol; 1984 Apr; 33(8):1195-203. PubMed ID: 6143562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells.
    Saunders PP; Spindler CD; Tan MT; Alvarez E; Robins RK
    Cancer Res; 1990 Sep; 50(17):5269-74. PubMed ID: 2143686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of action of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). VI. Biochemical and pharmacological studies on the degradation of thiazole-4-carboxamide adenine dinucleotide (TAD).
    Ahluwalia GS; Cooney DA; Marquez VE; Jayaram HN; Johns DG
    Biochem Pharmacol; 1986 Nov; 35(21):3783-90. PubMed ID: 2877671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines.
    Saunders PP; Kuttan R; Lai MM; Robins RK
    Mol Pharmacol; 1983 Mar; 23(2):534-9. PubMed ID: 6188036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
    Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
    Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydrogenase binding by tiazofurin anabolites.
    Goldstein BM; Bell JE; Marquez VE
    J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of thiazole-4-carboxamide adenine dinucleotide (TAD) levels in mononuclear cells of leukemic patients treated with tiazofurin.
    Zhen W; Jayaram HN; Weber G
    Biochem Pharmacol; 1991 Jan; 41(2):281-6. PubMed ID: 1989637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical consequences of resistance to a recently discovered IMP dehydrogenase inhibitor, benzamide riboside, in human myelogenous leukemia K562 cells.
    Jayaram HN; O'Connor A; Grant MR; Yang H; Grieco PA; Cooney DA
    J Exp Ther Oncol; 1996 Sep; 1(5):278-85. PubMed ID: 9414415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y; Goto H; Yoshino M; Ogasawara N
    Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective sensitivity to tiazofurin of human leukemic cells.
    Jayaram HN; Pillwein K; Nichols CR; Hoffman R; Weber G
    Biochem Pharmacol; 1986 Jun; 35(12):2029-32. PubMed ID: 3718544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic studies of two alcohol dehydrogenase-bound analogues of thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin.
    Li H; Hallows WH; Punzi JS; Marquez VE; Carrell HL; Pankiewicz KW; Watanabe KA; Goldstein BM
    Biochemistry; 1994 Jan; 33(1):23-32. PubMed ID: 8286346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of inosinate dehydrogenase.
    Kuttan R; Saunders P
    Biochem Int; 1987 Feb; 14(2):211-8. PubMed ID: 2883976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.